Barbara Valenta-singer PharmD

Barbara, an MD and pharmacologist by training, has over 25year industry experience gained at Pharmacia, Pfizer, Whyet, Baxter and Baxalta in different medical, clinical, safety and regulatory roles working in local, regional and global organizations. She holds the position of the Chief Medical Officer of the Fresenius Kabi Biosimilar unit. Before joining the industry, she had the opportunity to experience the perspective of a Regulatory Agency, Academia, and direct patient interactions. Her deep understanding of drug development results from filling operational and strategic assignments with exposure to small molecules and biologics, innovative compounds and Biosimilar.